Anish Bhatnagar
Chief Executive Officer chez SOLENO THERAPEUTICS, INC.
Fortune : 7 M $ au 31/03/2024
Profil
Anish Bhatnagar is currently the President, Chief Executive & Operating Officer at Soleno Therapeutics, Inc. He previously worked as a Principal at Titan Pharmaceuticals, Inc. from 2000 to 2006.
He also held a position as a Principal at Coulter Corp.
Dr. Bhatnagar completed his undergraduate degree at SMS Medical College & Hospital.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SOLENO THERAPEUTICS INC
0,47% | 01/04/2024 | 152 790 ( 0,47% ) | 7 M $ | 31/03/2024 |
Postes actifs de Anish Bhatnagar
| Sociétés | Poste | Début |
|---|---|---|
| SOLENO THERAPEUTICS, INC. | Chief Executive Officer | 01/01/2017 |
Anciens postes connus de Anish Bhatnagar
| Sociétés | Poste | Fin |
|---|---|---|
| TITAN PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2006 |
| Coulter Corp | Corporate Officer/Principal | - |
Formation de Anish Bhatnagar
| SMS Medical College & Hospital | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| TITAN PHARMACEUTICALS, INC. | Health Technology |
| SOLENO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
| Coulter Corp | Health Technology |
